| 000 | 01688 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250515003336.0 | ||
| 264 | 0 | _c20060209 | |
| 008 | 200602s 0 0 eng d | ||
| 022 | _a0269-2813 | ||
| 024 | 7 |
_a10.1111/j.1365-2036.2005.02649.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aYeomans, N D | |
| 245 | 0 | 0 |
_aPrevalence and incidence of gastroduodenal ulcers during treatment with vascular protective doses of aspirin. _h[electronic resource] |
| 260 |
_bAlimentary pharmacology & therapeutics _cNov 2005 |
||
| 300 |
_a795-801 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAspirin _xadverse effects |
| 650 | 0 | 4 |
_aDuodenal Ulcer _xchemically induced |
| 650 | 0 | 4 |
_aEndoscopy, Gastrointestinal _xmethods |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIncidence |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPlatelet Aggregation Inhibitors _xadverse effects |
| 650 | 0 | 4 | _aPrevalence |
| 650 | 0 | 4 |
_aRisk Assessment _xmethods |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 |
_aStomach Ulcer _xchemically induced |
| 700 | 1 | _aLanas, A I | |
| 700 | 1 | _aTalley, N J | |
| 700 | 1 | _aThomson, A B R | |
| 700 | 1 | _aDaneshjoo, R | |
| 700 | 1 | _aEriksson, B | |
| 700 | 1 | _aAppelman-Eszczuk, S | |
| 700 | 1 | _aLångström, G | |
| 700 | 1 | _aNaesdal, J | |
| 700 | 1 | _aSerrano, P | |
| 700 | 1 | _aSingh, M | |
| 700 | 1 | _aSkelly, M M | |
| 700 | 1 | _aHawkey, C J | |
| 773 | 0 |
_tAlimentary pharmacology & therapeutics _gvol. 22 _gno. 9 _gp. 795-801 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1365-2036.2005.02649.x _zAvailable from publisher's website |
| 999 |
_c15853903 _d15853903 |
||